» Articles » PMID: 12165621

Urinary Incontinence in Female Adolescents with Cystic Fibrosis

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2002 Aug 8
PMID 12165621
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Urinary incontinence is common in healthy women and occurs with increased frequency in adult women with chronic lung disease, including cystic fibrosis (CF). This study aimed to determine the prevalence, severity, and impact on daily life of urinary incontinence in female adolescents with CF.

Methods: An interviewer-administered questionnaire was conducted with females who were aged 12 years and older and attend the CF Clinic at the Royal Children's Hospital in Melbourne, Australia.

Results: Fifty-five (96%) of 57 eligible adolescents (age: 12-19 years) participated. Twenty-six (47%) reported ever having been incontinent of urine; 12 (22%) reported daytime incontinence twice a month or more. Median age of onset of incontinence was 13 years (range: 7-16 years). No relationship was seen with age, lung function, body mass index, or menarchal status. Coughing and laughing were the most commonly reported precipitants (affecting 84% and 68%, respectively). Of those with incontinence once a year or more, 42% reported that it sometimes prevented them from doing effective physiotherapy. Social life was affected by incontinence in approximately one third of respondents. Nearly half (42%) of affected adolescents had told no one, and only 2 had discussed the problem with their physician.

Conclusions: Urinary incontinence is common in female adolescents with CF and is not related to illness severity. Urinary incontinence has a negative impact on the performance of chest physiotherapy. Given the lack of adolescent report and knowledge of treatment availability, inquiry about symptoms of urinary incontinence should be part of the routine assessment of female adolescents with CF.

Citing Articles

Development of the Addenbrooke's MSK screening tool (AMST) for children and adolescents with cystic fibrosis.

Lock K, Nethercott S, Hamilton C, Grace F, Hall N, Lowndes L Heliyon. 2024; 10(4):e25403.

PMID: 38384566 PMC: 10878873. DOI: 10.1016/j.heliyon.2024.e25403.


Prevalence of Pelvic Incontinence in Patients With Cystic Fibrosis.

Neemuchwala F, Ahmed F, Nasr S Glob Pediatr Health. 2017; 4:2333794X17743424.

PMID: 29226186 PMC: 5714092. DOI: 10.1177/2333794X17743424.


Prevalence of Fecal Incontinence in Adults with Cystic Fibrosis.

Benezech A, Desmazes-Dufeu N, Baumstarck K, Bouvier M, Coltey B, Reynaud-Gaubert M Dig Dis Sci. 2017; 63(4):982-988.

PMID: 29086331 DOI: 10.1007/s10620-017-4825-2.


Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guideline.

Button B, Wilson C, Dentice R, Cox N, Middleton A, Tannenbaum E Respirology. 2016; 21(4):656-67.

PMID: 27086904 PMC: 4840479. DOI: 10.1111/resp.12764.


Recurrent pancreatitis: not just alcohol, gallstones and scorpion venom.

Walker L, Evison J, Garrett C J R Soc Med. 2004; 97(2):82-3.

PMID: 14749407 PMC: 1079298. DOI: 10.1177/014107680409700212.